Related Experiment Videos
Amyotrophic lateral sclerosis: Lou Gehrig's disease.
1University of Kansas School of Medicine, Wichita 67214-3199, USA.
American Family Physician
|April 8, 1999
Summary
Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disease affecting motor neurons, leading to severe muscle weakness and disability. Research focuses on neuronal metabolism, glutamate, and neurotoxins to develop new treatments for this debilitating condition.
Area of Science:
- Neurology
- Neuroscience
- Pathology
Background:
- Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, is a progressive neuromuscular disorder.
- It affects approximately 30,000 Americans, with an incidence of 1-2 per 100,000 people annually.
- ALS is typically diagnosed in middle age, affecting more men than women.
Observation:
- The disease presents with progressive muscle weakness, wasting, and fasciculations, impacting dexterity, gait, speech, and swallowing.
- Loss of upper and lower motor neuron function leads to complete disability, often necessitating ventilatory support and gastrostomy.
- Preserved functions include sphincter control, sensory perception, intellectual abilities, and skin integrity.
Findings:
- The exact etiology of ALS remains unknown.
- Current research investigates neuronal cell metabolism, particularly glutamate pathways, and the influence of neurotoxins and neurotrophic factors.
- New drug development is underway, targeting these underlying mechanisms.
Implications:
- Understanding ALS pathophysiology is crucial for developing effective therapeutic strategies.
- Targeting glutamate metabolism and neurotoxic pathways may offer novel treatment avenues.
- Continued research is essential for improving patient outcomes and managing complications associated with ALS.